Clinical Study Site

London WC1N3BG

0 studies enrolling now · 6 studies all time

What they study most

Bleeding, C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, Fabry Disease, Hemophilia A, Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A — Stopped early
• Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab — Completed
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G) — Completed
• A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study) — Completed
• Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years) — Completed
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed